Home-based brain stimulation plus intensive prolonged exposure for chronic pain and PTSD
Official title: Neuromodulation + Prolonged Exposure Therapy: Evaluation of a Technology-Enhanced, Entirely Remote 2-Week Integrated Treatment for Pain and PTSD
Run by The University of Texas Health Science Center, Houston · NCT07116109 · Data updated 2026-11-12
This trial will see if adding home-based transcranial direct current stimulation (tDCS) to an intensive, telemedicine-delivered prolonged exposure program helps people with chronic musculoskeletal pain and PTSD reduce symptoms and improve satisfaction compared with sham stimulation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years and up |
| Sex | All |
| Enrollment | 146 (estimated) |
| Sponsor | The University of Texas Health Science Center, Houston Academic / other |
| Locations | 2 sites (Charleston, South Carolina and 1 other locations) |
| Status | Recruiting |
| Started | July 1, 2025 |
| Main results expected | January 30, 2029 |
| Study ends | June 30, 2029 |
| Registry record updated | April 3, 2026 |
| Trial ID | NCT07116109 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with chronic non-cancer musculoskeletal pain for at least six months and a clinical diagnosis of PTSD (CAPS-5 and PCL-5 ≥30) who are willing to be randomized and complete telemedicine sessions are ideal candidates.
✕Probably not a fit
People with active psychosis, dementia, suicidal intent, current substance dependence, or those taking opioids or certain channel-blocking or NMDA antagonist medications are excluded and may not benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants are randomized to receive either active tDCS plus massed prolonged exposure (Massed-PE) or sham tDCS plus Massed-PE, with both interventions delivered primarily at home via telemedicine. The primary clinical targets are chronic musculoskeletal pain (≥6 months duration, DVPRS ≥3 and elevated PROMIS scores) and PTSD (diagnosed by CAPS-5 with PCL-5 ≥30). The study also measures process outcomes such as patient satisfaction, treatment attrition, and compliance, and explores changes in blood biomarkers of stress and inflammation tied to symptom change. Treatments combine a behavioral exposure protocol with portable neuromodulation to test an integrated, technology-enhanced approach.
Why it matters
Potential benefit: If successful, this approach could offer a scalable home-based treatment that reduces both chronic pain and PTSD symptoms and improves treatment engagement.
How similar studies have gone: Previous research has shown modest benefits of tDCS for pain and strong evidence for prolonged exposure in PTSD, but combining home-based tDCS with massed PE is relatively novel and not yet proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Presence of musculoskeletal, chronic, non-cancer pain with a rating of ≥ 3 out of 10 on a 0-10 on the Defense and Veterans Pain Rating Scale (DVPRS) and a pain intensity and interference score of 1 standard deviation above PROMIS normative data (see Measures section below). Symptoms will be required to be of at least six months duration and verified diagnosis in their medical chart authorized by informed consent * Diagnosis of PTSD assigned on the basis of the Clinician Administered PTSD Scale (CAPS-5) and PCL-5 ≥ 30 * willing to participate in study randomization, treatment assignment, and assessments. Exclusion Criteria: * Having a household member who is already enrolled in the study * Active psychosis or dementia at screening * Suicidal ideation with clear intent * Current substance dependence * current opioid medication for pain and/or current use of sodium channel blockers, calcium channel blockers, or N-Methyl-D-aspartate receptor antagonists, because these medications can block tDCS effects * pregnancy and/or lactation * concurrent enrollment in another pain clinical trial * tDCS or medical related contraindications such as open-injury TBI (penetrating injury), seizure disorder (independently of the type of TBI or condition causing the seizure disorder), pregnancy, implanted metal, claustrophobia * having pain that is not chronic, presence of severe and frequent migraines, fibromyalgia, or pain caused by a primary condition such as cancer.
Where it's running
-
Charleston VA Healthcare System
Charleston, South Carolina, United States Recruiting -
The University of Texas Health Science Center at Houston
Houston, Texas, United States Active not recruiting
Study contacts
- Principal investigator: Melba Hernandez-Tejada, PhD, DHA — The University of Texas Health Science Center, Houston
- Study coordinator: Melba Hernandez-Tejada, PhD, DHA
- Email: Melba.A.HernandezTejada@uth.tmc.edu
- Phone: 713 4862729
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Non-invasive vagus nerve stimulation (gammaCore) for PTSD
This study will test whether the handheld gammaCore device, which delivers mild electrical stimulation to the vagus nerve through the neck, can help adults with PTSD reduce their symptoms.
-
Building Ukraine's strength in PTSD treatment
This project will try the Reconsolidation of Traumatic Memories (RTM) protocol alongside standard PTSD treatments to see if it reduces symptoms in adults with PTSD living in Ukraine.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
-
Meaning-Based Psychotherapy for Adults with Chronic Pain
This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.
-
How chronic pain changes over time in kids with Duchenne Muscular Dystrophy
This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.